Violet/blue light activates Nrf2 signaling and modulates the inflammatory response of THP-1 monocytes

L. A. Trotter, D. Patel, S. Dubin, C. Guerra, V. McCloud, P. Lockwood, Regina L W Messer, J. C. Wataha, J. B. Lewis

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Several studies suggest that light in the UVA range (320-400 nm) activates signaling pathways that are anti-inflammatory and antioxidative. These effects have been attributed to Nrf2-mediated upregulation of "phase 2" genes such as heme oxygenase-1 (HO-1) that neutralize oxidative stress and metabolize electrophiles. Proteomics analysis previously had shown that small doses of blue light (400-500 nm) increased levels of peroxiredoxin phase 2 proteins in THP-1 monocytes, which led to our hypothesis that blue light activates Nrf2 signaling and thus may serve as an anti-inflammatory agent. THP-1 monocytes were treated with doses of blue light with and without lipopolysaccharide (LPS) inflammatory challenge. Cell lysates were tested for Nrf2 activation and HO-1 production. Treated cells were assessed for viability/mitochondrial activity via trypan blue exclusion and MTT assay, and secretion of two major pro-inflammatory cytokines, interleukin 8 (IL8) and tumor necrosis factor alpha (TNFα) was measured using ELISA. Blue light activated the phase 2 response in cultured THP-1 cells and was protective against LPS-induced cytotoxicity. Light pre-treatment also significantly reduced cytokine secretion in response to 0.1 μg ml-1 LPS, but had no anti-inflammatory effect at high LPS levels. This study is the first to report these effects using a light source that is approved for routine use on dental patients. Cellular responses to these light energies are worth further study and may provide therapeutic interventions for inflammation.

Original languageEnglish (US)
Pages (from-to)883-889
Number of pages7
JournalPhotochemical and Photobiological Sciences
Volume16
Issue number6
DOIs
StatePublished - Jan 1 2017

Fingerprint

monocytes
Lipopolysaccharides
secretions
Heme Oxygenase-1
Anti-Inflammatory Agents
Dosimetry
cells
Cytokines
interleukins
Peroxiredoxins
dosage
Oxidative stress
Trypan Blue
necrosis
Cytotoxicity
exclusion
Interleukin-8
viability
genes
pretreatment

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry

Cite this

Trotter, L. A., Patel, D., Dubin, S., Guerra, C., McCloud, V., Lockwood, P., ... Lewis, J. B. (2017). Violet/blue light activates Nrf2 signaling and modulates the inflammatory response of THP-1 monocytes. Photochemical and Photobiological Sciences, 16(6), 883-889. https://doi.org/10.1039/c6pp00299d

Violet/blue light activates Nrf2 signaling and modulates the inflammatory response of THP-1 monocytes. / Trotter, L. A.; Patel, D.; Dubin, S.; Guerra, C.; McCloud, V.; Lockwood, P.; Messer, Regina L W; Wataha, J. C.; Lewis, J. B.

In: Photochemical and Photobiological Sciences, Vol. 16, No. 6, 01.01.2017, p. 883-889.

Research output: Contribution to journalArticle

Trotter, LA, Patel, D, Dubin, S, Guerra, C, McCloud, V, Lockwood, P, Messer, RLW, Wataha, JC & Lewis, JB 2017, 'Violet/blue light activates Nrf2 signaling and modulates the inflammatory response of THP-1 monocytes', Photochemical and Photobiological Sciences, vol. 16, no. 6, pp. 883-889. https://doi.org/10.1039/c6pp00299d
Trotter, L. A. ; Patel, D. ; Dubin, S. ; Guerra, C. ; McCloud, V. ; Lockwood, P. ; Messer, Regina L W ; Wataha, J. C. ; Lewis, J. B. / Violet/blue light activates Nrf2 signaling and modulates the inflammatory response of THP-1 monocytes. In: Photochemical and Photobiological Sciences. 2017 ; Vol. 16, No. 6. pp. 883-889.
@article{4fbb8ea5e7fd4aca83f002cf75ac87df,
title = "Violet/blue light activates Nrf2 signaling and modulates the inflammatory response of THP-1 monocytes",
abstract = "Several studies suggest that light in the UVA range (320-400 nm) activates signaling pathways that are anti-inflammatory and antioxidative. These effects have been attributed to Nrf2-mediated upregulation of {"}phase 2{"} genes such as heme oxygenase-1 (HO-1) that neutralize oxidative stress and metabolize electrophiles. Proteomics analysis previously had shown that small doses of blue light (400-500 nm) increased levels of peroxiredoxin phase 2 proteins in THP-1 monocytes, which led to our hypothesis that blue light activates Nrf2 signaling and thus may serve as an anti-inflammatory agent. THP-1 monocytes were treated with doses of blue light with and without lipopolysaccharide (LPS) inflammatory challenge. Cell lysates were tested for Nrf2 activation and HO-1 production. Treated cells were assessed for viability/mitochondrial activity via trypan blue exclusion and MTT assay, and secretion of two major pro-inflammatory cytokines, interleukin 8 (IL8) and tumor necrosis factor alpha (TNFα) was measured using ELISA. Blue light activated the phase 2 response in cultured THP-1 cells and was protective against LPS-induced cytotoxicity. Light pre-treatment also significantly reduced cytokine secretion in response to 0.1 μg ml-1 LPS, but had no anti-inflammatory effect at high LPS levels. This study is the first to report these effects using a light source that is approved for routine use on dental patients. Cellular responses to these light energies are worth further study and may provide therapeutic interventions for inflammation.",
author = "Trotter, {L. A.} and D. Patel and S. Dubin and C. Guerra and V. McCloud and P. Lockwood and Messer, {Regina L W} and Wataha, {J. C.} and Lewis, {J. B.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1039/c6pp00299d",
language = "English (US)",
volume = "16",
pages = "883--889",
journal = "Photochemical and Photobiological Sciences",
issn = "1474-905X",
publisher = "Royal Society of Chemistry",
number = "6",

}

TY - JOUR

T1 - Violet/blue light activates Nrf2 signaling and modulates the inflammatory response of THP-1 monocytes

AU - Trotter, L. A.

AU - Patel, D.

AU - Dubin, S.

AU - Guerra, C.

AU - McCloud, V.

AU - Lockwood, P.

AU - Messer, Regina L W

AU - Wataha, J. C.

AU - Lewis, J. B.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Several studies suggest that light in the UVA range (320-400 nm) activates signaling pathways that are anti-inflammatory and antioxidative. These effects have been attributed to Nrf2-mediated upregulation of "phase 2" genes such as heme oxygenase-1 (HO-1) that neutralize oxidative stress and metabolize electrophiles. Proteomics analysis previously had shown that small doses of blue light (400-500 nm) increased levels of peroxiredoxin phase 2 proteins in THP-1 monocytes, which led to our hypothesis that blue light activates Nrf2 signaling and thus may serve as an anti-inflammatory agent. THP-1 monocytes were treated with doses of blue light with and without lipopolysaccharide (LPS) inflammatory challenge. Cell lysates were tested for Nrf2 activation and HO-1 production. Treated cells were assessed for viability/mitochondrial activity via trypan blue exclusion and MTT assay, and secretion of two major pro-inflammatory cytokines, interleukin 8 (IL8) and tumor necrosis factor alpha (TNFα) was measured using ELISA. Blue light activated the phase 2 response in cultured THP-1 cells and was protective against LPS-induced cytotoxicity. Light pre-treatment also significantly reduced cytokine secretion in response to 0.1 μg ml-1 LPS, but had no anti-inflammatory effect at high LPS levels. This study is the first to report these effects using a light source that is approved for routine use on dental patients. Cellular responses to these light energies are worth further study and may provide therapeutic interventions for inflammation.

AB - Several studies suggest that light in the UVA range (320-400 nm) activates signaling pathways that are anti-inflammatory and antioxidative. These effects have been attributed to Nrf2-mediated upregulation of "phase 2" genes such as heme oxygenase-1 (HO-1) that neutralize oxidative stress and metabolize electrophiles. Proteomics analysis previously had shown that small doses of blue light (400-500 nm) increased levels of peroxiredoxin phase 2 proteins in THP-1 monocytes, which led to our hypothesis that blue light activates Nrf2 signaling and thus may serve as an anti-inflammatory agent. THP-1 monocytes were treated with doses of blue light with and without lipopolysaccharide (LPS) inflammatory challenge. Cell lysates were tested for Nrf2 activation and HO-1 production. Treated cells were assessed for viability/mitochondrial activity via trypan blue exclusion and MTT assay, and secretion of two major pro-inflammatory cytokines, interleukin 8 (IL8) and tumor necrosis factor alpha (TNFα) was measured using ELISA. Blue light activated the phase 2 response in cultured THP-1 cells and was protective against LPS-induced cytotoxicity. Light pre-treatment also significantly reduced cytokine secretion in response to 0.1 μg ml-1 LPS, but had no anti-inflammatory effect at high LPS levels. This study is the first to report these effects using a light source that is approved for routine use on dental patients. Cellular responses to these light energies are worth further study and may provide therapeutic interventions for inflammation.

UR - http://www.scopus.com/inward/record.url?scp=85021633632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021633632&partnerID=8YFLogxK

U2 - 10.1039/c6pp00299d

DO - 10.1039/c6pp00299d

M3 - Article

C2 - 28379252

AN - SCOPUS:85021633632

VL - 16

SP - 883

EP - 889

JO - Photochemical and Photobiological Sciences

JF - Photochemical and Photobiological Sciences

SN - 1474-905X

IS - 6

ER -